Clinical Trials Logo

Clinical Trial Summary

Diabetic patients with macular edema and choroidal hyperpermeability (as manifested as a thick choroid on OCT (optical coherence tomography) and ICG hyperfluorescence on ICG) unresponsive to anti-VEGF (vascular endothelial growth factor) and steroid injections will be treated with spironolactone in addition to the continued treatment of anti-VEGF injections, specifically aflibercept (Eylea).

Clinical Trial Description

This is a non-randomized, prospective study of 10 patients referred during the years 2018 to 2020 with the diagnosis of Diabetic Macular Edema. Each patient was noted to have pachychoroid, choroidal hyperpermeability, and most important resistant to multiple anti-VEGF and steroid intravitreal injections, and have moderate vision loss. In addition, despite the fact that we use anti-VEGF medications, we do not know the levels of VEGF in the eye, nor do we have an explanation for the inability to respond to these drugs. This study will determine the degree of VEGF concentrations, response to anti-VEGF treatments, and determine biomarkers of inflammation as a means for explaining the cause of treatment resistance. Subsequently, another pathological process will be treated with spironolactone to see if the degree of contribution of choroidal hyperpermeability to the exudative process. ;

Study Design

Related Conditions & MeSH terms

NCT number NCT04853355
Study type Interventional
Source Wake Forest University Health Sciences
Contact Mark H. Nelson, MD MBA
Phone 336-971-5341
Email [email protected]
Status Not yet recruiting
Phase Phase 4
Start date June 1, 2021
Completion date July 1, 2022

See also
  Status Clinical Trial Phase
Active, not recruiting NCT00403884 - Selective RPE Laser Treatment (SRT) for Various Macular Diseases N/A
Recruiting NCT03571217 - Shanghai Beixinjing Diabetic Eyes Study
Completed NCT01689090 - Diameter Changes of Retinal Vessels During Hypoxia N/A
Not yet recruiting NCT04699864 - Evaluation of NeoRetina Artificial Intelligence Algorithm for the Screening of Diabetic Retinopathy at the CHUM N/A
Recruiting NCT03750149 - Reading Analysis in Ophthalmologic Patients N/A
Completed NCT00873106 - Retinal Thickness and Volume Estimates Given by Time Domain and Spectral Optical Coherence Tomography N/A
Not yet recruiting NCT01549132 - Retinal Oximtery Following Treatment for Diabetic Maculopathy N/A